Results 251 to 260 of about 245,676 (315)
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus. [PDF]
Wang M +22 more
europepmc +1 more source
Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection. [PDF]
Wang J +10 more
europepmc +1 more source
Protective human antibodies against Powassan virus. [PDF]
Fallon G +10 more
europepmc +1 more source
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. [PDF]
Korber B +15 more
europepmc +1 more source
Bivalent mRNA booster encoding virus-like particles elicits potent polyclass receptor-binding domain antibodies in pre-vaccinated mice. [PDF]
Fan C +12 more
europepmc +1 more source
Editorial for Special Issue "Molecular Research in Vaccinology and Vaccine Development". [PDF]
Farsang A.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Proceedings of the 2016 ACM SIGCOMM Conference, 2016
Should applications receive special treatment from the network? And if so, who decides which applications are preferred? This discussion, known as net neutrality, goes beyond technology and is a hot political topic. In this paper we approach net neutrality from a user's perspective.
Yiannis Yiakoumis +2 more
openaire +1 more source
Should applications receive special treatment from the network? And if so, who decides which applications are preferred? This discussion, known as net neutrality, goes beyond technology and is a hot political topic. In this paper we approach net neutrality from a user's perspective.
Yiannis Yiakoumis +2 more
openaire +1 more source

